Indication
Heart Failure With Volume Overload
Aliases
Heart failure
1 clinical trial
1 product
Clinical trial
An Open Label, Tolvaptan-controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Multiple Ascending Dose of HRS-9057 in Heart Failure With Volume OverloadStatus: Not yet recruiting, Estimated PCD: 2024-09-20
Product
HRS-9057